Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE VANNETAISE : revenue, balance sheet and financial ratios

SELARL PHARMACIE VANNETAISE is a French company founded 10 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in VANNES (56000), this company of category PME shows in 2020 a net income positive of 190 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE VANNETAISE (SIREN 819526757)
Indicator 2020 2019 2018 2017
Revenue N/C N/C N/C N/C
Net income 190 286 € 186 941 € 187 827 € 126 093 €
EBITDA N/C N/C N/C N/C
Net margin N/C N/C N/C N/C

Revenue and income statement

In 2020, SELARL PHARMACIE VANNETAISE generates positive net income of 190 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2020: 126 k€ -> 190 k€.

Net income (2020) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

190 286 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 196%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 31%. The balance between equity and debt is satisfactory.

Debt ratio (2020) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

195.999%

Financial autonomy (2020) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

31.268%

Asset age ratio (2020) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

56.4%

Solvency indicators evolution
SELARL PHARMACIE VANNETAISE

Sector positioning

Debt ratio
196.0 2020
2018
2019
2020
Q1: 33.2
Med: 96.78
Q3: 238.43
Average -8 pts over 3 years

In 2020, the debt ratio of SELARL PHARMACIE VANNETAISE (196.00) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
31.27% 2020
2018
2019
2020
Q1: 23.59%
Med: 41.65%
Q3: 61.95%
Average +11 pts over 3 years

In 2020, the financial autonomy of SELARL PHARMACIE VANNETAISE (31.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 353.84. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2020) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

353.839

Liquidity indicators evolution
SELARL PHARMACIE VANNETAISE

Sector positioning

Liquidity ratio
353.84 2020
2018
2019
2020
Q1: 133.12
Med: 181.89
Q3: 251.9
Excellent

In 2020, the liquidity ratio of SELARL PHARMACIE VANNETAISE (353.84) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of SELARL PHARMACIE VANNETAISE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 180 transactions of similar company sales in 2020, the value of SELARL PHARMACIE VANNETAISE is estimated at 2 689 247 € (range 1 793 152€ - 3 628 520€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2020
180 transactions
1793k€ 2689k€ 3628k€
2 689 247 € Range: 1 793 152€ - 3 628 520€
NAF 5 année 2020

Valuation method used

Net Income Multiple
190 286 € × 14.1x = 2 689 247 €
Range: 1 793 152€ - 3 628 520€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 180 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE VANNETAISE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE VANNETAISE

What is the revenue of SELARL PHARMACIE VANNETAISE ?

The revenue of SELARL PHARMACIE VANNETAISE is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE VANNETAISE profitable?

Yes, SELARL PHARMACIE VANNETAISE generated a net profit of 190 k€ in 2020.

Where is the headquarters of SELARL PHARMACIE VANNETAISE ?

The headquarters of SELARL PHARMACIE VANNETAISE is located in VANNES (56000), in the department Morbihan.

Where to find the tax return of SELARL PHARMACIE VANNETAISE ?

The tax return of SELARL PHARMACIE VANNETAISE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE VANNETAISE operate?

SELARL PHARMACIE VANNETAISE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.